Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care.
The post The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease appeared first on MedCity News.
